Coronary artery aneurysms—a truly rare entity or simply unrecognized so far?

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Is microcephaly a so-far unrecognized feature of XYY syndrome?☆

•47,XYY syndrome is a frequent sex chromosome aneuploidy.•Overview of characteristic symptoms of 47,XXY•First report of 47,XYY and microcephaly in a preterm child•Brief differential diagnosis of microcephaly.

متن کامل

Syphilitic hepatitis: rare or just unrecognized?

Syphilis is a chronic, infectious, sexually transmitted disease caused by Treponema pallidum and can affect all tissues and all organs (1). Untreated syphilis progresses through four stages: primary, secondary, latent and tertiary (1). Among the less common manifestations of the secondary stage is syphilitic hepatitis ; syphilis remains one of the unrecognized etiolo-gies of liver dysfunction (...

متن کامل

Long insular artery infarction: characteristics of a previously unrecognized entity.

BACKGROUND AND PURPOSE The infarctions arising in the long insular arteries of the M2 segment have been poorly described in the past. The purpose of this study was to investigate the incidence, clinical characteristics, and pathogenesis of long insular artery infarcts. MATERIALS AND METHODS Patients with acute isolated infarcts in territories of the long insular arteries and lenticulostriate ...

متن کامل

Accessory Hepatic Lobe - A ‘ not so Rare ’ Entity

Introduction: Accessory Hepatic Lobe (AHL) is an uncommon developmental anomaly usually asymptomatic and reported as an incidental finding on cross-sectional imaging, laparotomy or autopsy. With increasing number of cases undergoing cross-sectional imaging the detection rate of AHL has increased. Aim: The aim of this study was to assess the incidence and describe the imaging features of AHL usi...

متن کامل

Sunitinib-induced thyrotoxicosis - a not so rare entity.

BACKGROUND/AIM The tyrosine kinase inhibitor (TKI) sunitinib malate is nowadays a standard first-line treatment option for patients with metastatic clear-cell renal cell carcinoma (mRCC). The aim of this study was to evaluate the incidence and clinical course of thyrotoxicosis in our cohort of patients treated with sunitinib. PATIENTS AND METHODS Medical records of all patients treated with f...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Oxford Medical Case Reports

سال: 2019

ISSN: 2053-8855

DOI: 10.1093/omcr/omz009